These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29437827)

  • 1. Normocalcaemic primary hyperparathyroidism: a pragmatic approach.
    Babwah F; Buch HN
    J Clin Pathol; 2018 Apr; 71(4):291-297. PubMed ID: 29437827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.
    Gómez-Ramírez J; Mihai R
    Langenbecks Arch Surg; 2017 Nov; 402(7):1103-1108. PubMed ID: 28823005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency.
    Das G; Eligar V; Govindan J; Bondugulapati LN; Okosieme O; Davies S
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):462-9. PubMed ID: 25468998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?
    Wu KCJ; Anpalahan M
    Intern Med J; 2023 Jan; 53(1):112-118. PubMed ID: 34435736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?
    Aojula N; Khan S; Gittoes N; Hassan-Smith Z
    Ther Adv Endocrinol Metab; 2021; 12():2042018821995370. PubMed ID: 33717430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form?
    Gómez-Ramírez J; Gómez-Valdazo A; Luengo P; Porrero B; Osorio I; Rivas S
    Am J Surg; 2020 Jan; 219(1):150-153. PubMed ID: 31662196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?
    Chen G; Xue Y; Zhang Q; Xue T; Yao J; Huang H; Liang J; Li L; Lin W; Lin L; Shi L; Cai L; Wen J
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2420-4. PubMed ID: 25668199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normocalcaemic primary hyperparathyroidism: An update on diagnostic and management challenges.
    Dawood NB; Yan KL; Shieh A; Livhits MJ; Yeh MW; Leung AM
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):519-527. PubMed ID: 32803770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical therapy concept in primary hyperparathyroidism].
    Rusterholz D; Müller W
    Schweiz Med Wochenschr Suppl; 2000; 116():62S-65S. PubMed ID: 10780075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to manage an isolated elevated PTH?
    Souberbielle JC; Cavalier E; Cormier C
    Ann Endocrinol (Paris); 2015 May; 76(2):134-41. PubMed ID: 25882890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normocalcaemic, vitamin D-sufficient hyperparathyroidism - high prevalence and low morbidity in the general population: A long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden.
    Kontogeorgos G; Trimpou P; Laine CM; Oleröd G; Lindahl A; Landin-Wilhelmsen K
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):277-84. PubMed ID: 25988687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperparathyroidism.
    Bilezikian JP; Bandeira L; Khan A; Cusano NE
    Lancet; 2018 Jan; 391(10116):168-178. PubMed ID: 28923463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
    Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
    Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperparathyroidism.
    Fraser WD
    Lancet; 2009 Jul; 374(9684):145-58. PubMed ID: 19595349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid disorders.
    Michels TC; Kelly KM
    Am Fam Physician; 2013 Aug; 88(4):249-57. PubMed ID: 23944728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of patients with raised serum calcium level in primary care, Sweden.
    Dalemo S; Hjerpe P; Boström Bengtsson K
    Scand J Prim Health Care; 2006 Sep; 24(3):160-5. PubMed ID: 16923625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of biochemical and radiographic signs of hyperparathyroidism in chronic renal disease.
    Nilsson P; Malmaeus J; Wide L; Danielson BG
    Scand J Urol Nephrol Suppl; 1984; 84():I1-25. PubMed ID: 6393321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.